Test - Ecosystem agenda: Difference between revisions

From Bioblast
No edit summary
No edit summary
 
(154 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{Publication
<p style="text-align:center; width:100%;">
|title=Stadlmann S, Renner K, Pollheimer J, Moser PL, Zeimet AG, Offner FA, Gnaiger E (2006) Preserved coupling of oxidative phosphorylation but decreased mitochondrial respiratory capacity in IL-1ß treated human peritoneal mesothelial cells. Cell Biochem Biophys 44:179-86.
<pic src="/images/0/08/O2k-News_icon.jpg" width=9% height=intrinsic link="https://wiki.oroboros.at/index.php/OROBOROS_INSTRUMENTS" />
|info=[http://www.ncbi.nlm.nih.gov/pubmed/16456220 PMID: 16456220], [[File:PDF.jpg|100px|link=http://www.bioblast.at/images/c/cb/Stadlmann_2006_Cell_Biochem_Biophys.pdf |Bioblast pdf]]
&nbsp;&nbsp;&nbsp;
|authors=Stadlmann S, Renner K, Pollheimer J, Moser PL, Zeimet AG, Offner FA, Gnaiger E
<pic src="/images/3/3b/O2k-Support.jpg" width=9% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Open_Support" />
|year=2006
&nbsp;&nbsp;&nbsp;
<pic src="/images/6/6d/O2k-Publications.jpg" width=9% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Publications:_Topics" />
&nbsp;
<pic src="/images/4/4c/O2k-Workshops.jpg" width=9% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Events" />
&nbsp;
<pic src="/images/9/96/O2k-Network.png" width=9% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Network" />
&nbsp;
<pic src="/images/e/e7/O2k-Feedback.jpg" width=9% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Feedback" />
&nbsp;
<pic src="/images/8/84/NextGenO2k_logo_nobkg.png" width=15% height=intrinsic link="https://wiki.oroboros.at/index.php/NextGen-O2k" />
</p>


|journal=Cell Biochem Biophys
|abstract=The peritoneal mesothelium acts as a regulator of serosal responses to injury, infection, and neoplastic diseases. After inflammation of the serosal surfaces, proinflammatory cytokines induce an “activated” mesothelial cell phenotype, the mitochondrial aspect of which has not previously been studied. After incubation of cultured human peritoneal mesothelial cells with interleukin (IL)-1β for 48 h, respiratory activity of suspended cells was analyzed by high-resolution respirometry. Citrate synthase (CS) and lactate dehydrogenase (LDH) activities were determined by spectrophotometry. Treatment with IL-1β resulted in a significant decline of respiratory capacity (''p'' < 0.05). Respiratory control ratios (i.e., uncoupled respiration at optimum carbonyl cyanide p-trifluoromethoxyphenylhydrazone concentration divided by oligomycin inhibited respiration measured in unpermeabilized cells) remained as high as 11, indicating well-coupled mitochondria and functional integrity of the inner mitochondrial membrane. Whereas respiratory capacities of the cells declined in proportion with decreased CS activity (''p'' < 0.05), LDH activity increased (''p'' < 0.05). Taken together, these results indicate that IL-1β exposure of peritoneal mesothelial cells does not lead to irreversible defects or inhibition of specific components of the respiratory chain, but is associated with a decrease of mitochondrial content of the cells that is correlated with an increase in LDH (and thus glycolytic) capacity.
|keywords=Peritoneal mesothelial cells, Interleukin-1β, Mitochondria, Respiration, Citrate synthase, Lactate dehydrogenase, Cell viability
|mipnetlab=AT Innsbruck Gnaiger E, DE Regensburg Renner-Sattler K
}}
{{Labeling
|area=Respiration, mt-Biogenesis;mt-density, Pharmacology;toxicology
|injuries=Cell death
|organism=Human
|tissues=Endothelial;epithelial;mesothelial cell
|preparations=Intact cells
|topics=Coupling efficiency;uncoupling, Substrate
|couplingstates=ROUTINE, ET
|instruments=Oxygraph-2k
}}
__TOC__
<br />
[[File:Stadlmann 2006 Cell Biochem Biophys Fig1B-updated.jpg|right|500px]]
<br />


== Cell coupling control protocol ==
<!-- This page is for format and layout only. To modify the content use the appropriate templates (shown at the end of this page below save button) -->__NOTOC____NOEDITSECTION__{{DISPLAYTITLE:<span style="display:none">{{FULLPAGENAME}}</span>}}
::::» [[1ce;2ceSD;3ceOmy;4ceU-]]
{| style="width: 100%; text-align: center"
<br />
| <pic src="/images/0/08/O2k-News_icon.jpg" width=50% height=intrinsic link="https://wiki.oroboros.at/index.php/OROBOROS_INSTRUMENTS" />
| <pic src="/images/3/3b/O2k-Support.jpg" width=50% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Open_Support" />
| <pic src="/images/6/6d/O2k-Publications.jpg" width=50% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Publications:_Topics" />
| <pic src="/images/4/4c/O2k-Workshops.jpg" width=50% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Events" />
| <pic src="/images/9/96/O2k-Network.png" width=50% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Network" />
| <pic src="/images/e/e7/O2k-Feedback.jpg" width=50% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Feedback" />
| <pic src="/images/8/84/NextGenO2k_logo_nobkg.png" width=50% height=intrinsic link="https://wiki.oroboros.at/index.php/NextGen-O2k" />
|}
----
----




{| class="wikitable" border="1"
<!--        BANNER ACROSS TOP OF PAGE        -->
|-
{{Template:Bioblast_banner}}
! Step
<div id="mp-topbanner" style="clear:both; position:relative; box-sizing:border-box; width:100%; margin:1.2em 0 6px; min-width:47em; background-color:#f9f9f9; color:#000; white-space:nowrap;">
! <Symbol in 2006 publication>
</div>
! Respiratory flow
! Comment


|-
<!--        CURRENT WEEK        -->
| 1ce
{| role="presentation" id="mp-upper" style="width: 100%; margin-top:4px; border-spacing: 0px;"
| < E >
| [[ROUTINE]], ''R''


(Eq 1.1) 1ce = ''R''<sub>ce</sub>
<!--        1ST BOX | CURRENT WEEK AGENDA - LEFT        -->
 
| id="mp-left" class="MainPageBG" style="width:65%; padding:0; background:#f0f5ff; vertical-align:top; color:#000;"|
(Eq 1.2) 1ce = ''R''<sub>vce</sub> + ROX<sub>dce</sub>
<div id="mp-tfa-h2" style="margin:0.5em; background:#2856ba; font-family:inherit; font-size:120%; font-weight:bold; color:#ffffff; padding:0.2em 0.4em;">Bioblast Agenda - 2022 week {{CURRENTWEEK}}</div>
| [[living cells |Cells (ce=vce+dce)]]; living cells (ce) are viable (vce) or dead (dce); if mitochondria of dce are intact, respiration of dce is identical to digitonin-permeabilized cells ([[Permeabilized tissue or cells |pce]]). dce without substrate are in a state of ROX<sub>dce</sub>.
<div id="mp-tfa" style="padding:0.1em 0.6em;">
 
{{Current_week_ecosystem_agenda}}
(Eq 2) Definition: ''R''<sub>vce</sub> = ''R''<sub>vce</sub>(mt) + ROX<sub>vce</sub>
<br />
 
</div>
|-
| 2ceSD
| < S >
| ''R'' + S<sub>''P''</sub>
 
(Eq 3) 2ceSD = ''R''<sub>vce</sub> + S<sub>''P'',dce</sub>
| [[ROUTINE]] respiration of vce is not affected by extracellular succinate and ADP (SD); dce (with intact mt) are in state S<sub>''P'',dce</sub>. ''Limitation'': In the absence of rotenone, S-OXPHOS capacity may be underestimated in some types of mitochondria, whereas it is overestimated if anaplerotic pathways from malate are active, e.g. mt-malic enzyme would additionally activate the N-pathway.
 
(Eq 4) Definition: S<sub>''P'',dce</sub> = S<sub>''P'',dce</sub>(mt) + ROX<sub>dce</sub>
|-
| 3ceOmy
| < O >
| [[LEAK]], ''L'' + S<sub>''L''</sub>


(Eq 5) 3ceOmy = ''L''<sub>vce</sub> + S<sub>''L'',dce</sub>
<!--        1ST BOX | OROBOROS OF THE MONTH - LEFT        -->
| vce and dce are in the LEAK state.
<div style="margin:0.5em; background:#cedff2; font-family:inherit; font-size:120%; font-weight:bold; color:#000; padding:0.2em 0.4em;">Oroboros of the month</div>
<div id="mp-tfa" style="padding:0.1em 0.6em;">
{{Template:Oroboros picture of the month}}
| style="border:1px solid transparent;"|
| style="border:1px solid transparent;"|


|-
<!--        2ND BOX | IN FOCUS - RIGHT        -->
| 4ceU
| id="mp-right" class="MainPageBG" style="width:35%; padding:0; background:#f5faff; vertical-align:top;"|
| < 3u >
<div style="margin:0.5em; background:#cedff2; font-family:inherit; font-size:120%; font-weight:bold; color:#FF0000; padding:0.2em 0.4em;">In focus</div>
| [[Electron transfer pathway]], ''E'' + S<sub>''E''</sub>
<div id="mp-itn" style="padding:0.1em 0.6em;"><div id="mp-itn" style="padding:0em 0em;">
<p style="text-align:center; width:100%;><big>'''Check out [https://www.bioenergetics-communications.org/index.php/bec BEC]'s latest publications!'''</big> </div></p>
<gallery mode="packed">
Image:BEC2022.15.jpg|[https://www.bioenergetics-communications.org/index.php/bec/article/view/dambrova_2022 Mitochondrial metabolites acylcarnitines]|link=https://www.bioenergetics-communications.org/index.php/bec/article/view/dambrova_2022
Image:BEC2022.16.jpg|[https://www.bioenergetics-communications.org/index.php/bec/article/view/komlodi_2022 Protonmotive force]|link=https://www.bioenergetics-communications.org/index.php/bec/article/view/komlodi_2022
</gallery>
<gallery mode="packed">
Image:BEC2022.17.jpg|[https://www.bioenergetics-communications.org/index.php/bec/article/view/alencar_2022 Trypanosoma bruceimetabolic network]|link=https://www.bioenergetics-communications.org/index.php/bec/article/view/alencar_2022
Image:BEC2022.18.jpg|[https://www.bioenergetics-communications.org/index.php/bec/article/view/gainutdinov_2022 Calcium homeostasis in ALS patients’ fibroblasts]|link=https://www.bioenergetics-communications.org/index.php/bec/article/view/gainutdinov_2022
</gallery>


(Eq 6.1) 4ceU = ''E''<sub>vce</sub> + S<sub>''E'',dce</sub>


(Eq 6.2) 4ceU = ''E''<sub>vce</sub>(mt) + S<sub>''E'',dce</sub>(mt) + ROX<sub>ce</sub>
| vce and dce are in the ET pathway state.


(Eq 7.1) Definition: ''E''<sub>vce</sub> = ''E''<sub>vce</sub>(mt) + ROX<sub>vce</sub>


(Eq 7.2) Definition: S<sub>''E'',dce</sub> = S<sub>''E'',dce</sub>(mt) + ROX<sub>dce</sub>
</div>
 
<!--        STAY ALERT        -->
|-
<div style="margin:0.5em; background:#cedff2; font-family:inherit; font-size:120%; font-weight:bold; color:#000; padding:0.2em 0.4em;">Stay alert</div>
| 5ceRot
<div id="mp-itn" style="padding:0.1em 0.6em;">{{Oroboros Ecosystem Agenda list}}</div>
| < R >
| [[ROX]] + S<sub>''E''</sub>
 
(Eq 8.1) 5ceRot = ROX<sub>ce</sub> + S<sub>''E'',dce</sub>(mt)
 
(Eq 8.2) 5ceRot = ROX<sub>vce</sub> + S<sub>''E'',dce</sub>
 
| vce are in the ROX state, since succinate is not generated intracellularly after blocking CI by Rot and thus interrjupting the TCA cycle; dce (with intact mt) are in the S-ET-pathway state.
 
|-
| 6ceAma
| < A >
| [[ROX]]
 
(Eq 9) 6ceAma = ROX<sub>ce</sub>
| All ce are in the ROX state.
 
(Eq 10) Definition: ROX<sub>ce</sub> = ROX<sub>vce</sub> + ROX<sub>dce</sub>


<!--        ABOUT BIOBLAST        -->
<div style="margin:0.5em; background:#cedff2; font-family:inherit; font-size:120%; font-weight:bold; color:#000; padding:0.2em 0.4em;">Bioblast: About</div>
<div id="mp-itn" style="padding:0.1em 0.6em;">[[File:BB-Bioblast.jpg|left|85px|link=Bioblast:About]]'''Bioblast''' is an open access platform, including '''[[MitoPedia]]''' as a glossary and index for mitochondrial and chloroplast physiology, hosting '''[[MitoGlobal]]''', and supporting the journal '''[[Bioenergetics Communications]]''' and the '''[[Oroboros Ecosystem]]'''. </br>[[Bioblast:About|» More datails]]</div>
|}
|}


[[File:Stadlmann 2006 Cell Biochem Biophys cell mortality index.jpg|left|400px|Cell membrane permeability indexes]]
<!--        NEXT AND PREVIOUS AGENDA        -->
 
{| role="presentation" id="mp-upper" style="width: 100%; margin-top:4px; border-spacing: 0px;"
[[File:Stadlmann 2006 Cell Biochem Biophys Fig2A-updated.jpg|right|300px|Cell membrane permeability indexes]]
<!--       3 NEXT AGENDA        -->
 
| id="mp-left" class="MainPageBG" style="width:65%; padding:0; background:#f5fffa; vertical-align:top; color:#000;"|
== Cell membrane permeability index from the CCP ==
<div id="mp-tfa-h2" style="margin:0.5em; background:#cef2e0; font-family:inherit; font-size:120%; font-weight:bold; color:#000; padding:0.2em 0.4em;">Next Bioblast Agenda 2022</div>
 
<div id="mp-dyk" style="padding:0.1em 0.6em 0.5em;">
:::: In many studies of respiration using '[[living cells]]', respiratory [[flow]], ''I''<sub>O2</sub>, is expressed per million cells. The total number of cells, ''N''<sub>ce</sub>, is the sum of viable cells ''N''<sub>vce</sub> and dead cells ''N''<sub>dce</sub>. Cell viability is the ratio of viable cells in the total cell count, ''N''<sub>vce</sub>/''N''<sub>ce</sub>. Cell viability can be calculated from respirometric indices, based on the assumption that respiratory integrity of mitochondria is maintained in dce suspended in mitochondrial respiration medium [[MiR05]].
[[File:Expand.png|right|45px|Click on [Expand] or [Collapse]]
 
<div class="toccolours mw-collapsible mw-collapsed">
:::: The labels of the axes show the respiratory states as steps (mark names), and respiratory states.
 
:::: The two indexes derived from (i) the succinate control step, and (ii) the antimycin A control step are in close agreement (modified Fig. 2A from Stadlmann et al 2006).
 
 
=== Succinate control step ===
 
{| class="wikitable" border="1"
|-
! Step
! <Symbol in 2006 publication>
! Change of respiratory flow
! Comment
 
|-
| 2ceSD-1ce
 
| < S-E >
| (Eq 11) 2ceSD-1ce = S<sub>''P'',dce</sub>(mt)
| Stimulation of respiration by succinate & ADP (SD) in dead cells (dce, with intact mt) over endogenous ROUTINE respiration (''R'') in all counted cells (ce). vce are not permeable to SD, and are not stimulated by SD. dce are depleted of substrates and adenylates. Hence SD stimulates mitochondrial respiration in dce, and the difference 2SD-1ce equals the ROX-corrected (mitochondrial) S-OXPHOS capacity in dce, S<sub>''P'',dce</sub> - ROX<sub>dce</sub> = S<sub>''P'',dce</sub>(mt).
 
|-
| 4ceU – 1ce
| < 3u-E >
| (Eq 12) 4ceU-1ce = ''E''<sub>vce</sub>  + S<sub>''E'',dce</sub>(mt) - ''R''<sub>''vce''</sub>
| Total capacity over endogenous ROUTINE respiration in ce=vce+dce (viable and dead 
cells). All oligomycin-inhibited cells are stimulated by uncouplers (4ceU), because intact cell membranes are permeable for the uncoupler and respiration is supported by endogenous substrates in vce, whereas dce respire on succinate.
 
(Eq 6.2) 4ceU = ''E''<sub>vce</sub>(mt) + S<sub>''E'',dce</sub>(mt) + ROX<sub>ce</sub>
 
(Eq 1.2) 1ce = ''R''<sub>vce</sub> + ROX<sub>dce</sub>
 
(Eq 1.3) 1ce = ''R''<sub>vce</sub>(mt) + ROX<sub>ce</sub>
 
(Eq 1.4) 1ce = ''R''<sub>vce</sub> - ROX<sub>vce</sub> + ROX<sub>ce</sub>
 
Use (Eq 6.2) and (Eq 1.3)
 
(Eq 12.1) 4ceU-1ce = ''E''<sub>vce</sub>(mt) + S<sub>''E'',dce</sub>(mt) {+ ROX<sub>ce</sub>} - ''R''<sub>vce</sub>(mt) {- ROX<sub>ce</sub>}
 
(Eq 12.2) 4ceU-1ce = ''E''<sub>vce</sub>(mt) - ''R''<sub>vce</sub>(mt) + S<sub>''E'',dce</sub>(mt)
 
(Eq 13) Definition: [[Excess E-R capacity]], ''ExR''<sub>vce</sub>(mt) = ''E''<sub>vce</sub>(mt) - ''R''<sub>vce</sub>(mt)
 
Use (Eq 12.2) and (Eq 13) to obtain (Eq 12.3).
 
(Eq 12.3) 4ceU-1ce = ''ExR''<sub>vce</sub>(mt) + S<sub>''E'',dce</sub>(mt)


{|
| [[Image:O2k-News icon.jpg|75px|Bioblast Agenda]]
| >>>>>>> - Click on the right: [Expand] or [Collapse] - >>>>>>>
|}
|}
<div class="mw-collapsible-content"><br />


:::* '''Succinate control and normalization of the cell membrane permeability index, dce/ce'''
<!-- Cut and paste before next week up to here -->
:::: '''Mortality index (S-control)'''
{{Next_oroboros_ecosystem_agenda}}
::::* (Eq 14.1) dce/ce = (2ceSD - 1ce) / (4ceU - 1ce)
:::::: Use (Eq 11) and (Eq 12.2)
| style="border:1px solid transparent;"|
::::* (Eq 14.2) dce/ce = S<sub>''P'',dce</sub>(mt) / [''E''<sub>vce</sub>(mt) + S<sub>''P'',dce</sub>(mt) - ''R''<sub>vce</sub>(mt)]
<!--       4 ARCHIVE AGENDA        -->
:::::: Use (Eq 11) and (Eq 12.3)
::::* (Eq 14.3) dce/ce = S<sub>''P'',dce</sub>(mt) / [''ExR''<sub>vce</sub>(mt) + S<sub>''P'',dce</sub>(mt)]
 
:::: '''Viability index (S-control)'''
::::* (Eq 15.1) 1-dce/ce = 1- (2ceSD - 1ce) / (4ceU - 1ce)
::::* (Eq 15.2) 1-dce/ce = (4ceU - 2ceSD) / (4ceU - 1ce)
::::* (Eq 15.3) 1-dce/ce = vce/ce
:::::: Use (Eq 6.1) 4U = ''E''<sub>vce</sub> + S<sub>''E'',dce</sub>
 
:::::: Use (Eq 3) 2SD = ''R''<sub>vce</sub> + S<sub>''P'',dce</sub>
 
:::::: Use (Eq 1.1) 1ce = ''R''<sub>ce</sub>
 
::::* (Eq 16.1) 4ceU - 2ceSD = ''E''<sub>vce</sub> - ''R''<sub>vce</sub> + S<sub>''E'',dce</sub> - S<sub>''P'',dce</sub>
 
::::* (Eq 17.1) 4ceU - 1ce = ''E''<sub>vce</sub> + S<sub>''E'',dce</sub> - ''R''<sub>ce</sub>


::::* (Eq 17.2) 4ceU - 1ce = ''E''<sub>vce</sub>(mt) + S<sub>''E'',dce</sub>(mt)
| id="mp-right" class="MainPageBG" style="width:35%; padding:0; background:#f5fffa; vertical-align:top;"|
<div style="margin:0.5em; background:#cef2e0; font-family:inherit; font-size:120%; font-weight:bold; color:#000; padding:0.2em 0.4em;">Last week and before</div>
<div id="mp-otd" style="padding:0.1em 0.6em 0.5em;">
» [[Oroboros Ecosystem Agenda 2022 Archive]]  <br/>
» [[Oroboros Ecosystem Agenda 2021 Archive]]  </div>


::::* (Eq 18) vce/ce = ''E''<sub>vce</sub> - ''R''<sub>vce</sub> + S<sub>''E'',dce</sub> - S<sub>''P'',dce</sub> / [''E''<sub>vce</sub>(mt) + S<sub>''E'',dce</sub>(mt)]
::::* Limiting case of 100% viability (''N''<sub>vce</sub>=''N''<sub>ce</sub>): S<sub>''P'',dce</sub>(mt) = S<sub>''P'',dce</sub>(mt) = 0; vce/ce = 1
::::* Limiting case of 0% viability (''N''<sub>dce</sub>=''N''<sub>ce</sub>): ''E''<sub>vce</sub> = 0; ''R''<sub>vce</sub> = 0; S<sub>''E'',dce</sub> - S<sub>''P'',dce</sub> ~ 0; vce/ce ~ 0
:::::: If all cells are permeable (dce), then the viability index equals 0, since S<sub>''P''</sub> and ''ExR''=S<sub>''E''</sub> are practically identical in many types of mitochondria, then S<sub>''P''</sub>/S<sub>''E''</sub> = 1.
=== Antimycin A control step ===
{| class="wikitable" border="1"
|-
! Step
! <Symbol in 2006 publication>
! Change of respiratory flow
! Comment
|-
| 5ceRot-6ceAma
| < R-A >
| (Eq 19) 5ceRot-6ceAma = S<sub>''E'',dce</sub>(mt)
| Succinate-supported respiration in dce (in the presence of the CI inhibitor rotenone, Rot) over antimycin A–inhibited residual oxygen consumption (Ama) of all cells. This effect is specific for dce in the presence of succinate and uncoupler.
(Eq 19.1) 5ceRot-6ceAma = S<sub>''E'',dce</sub> + ROX<sub>vce</sub> - ROX<sub>ce</sub>
Use (Eq 10) ROX<sub>vce</sub> - ROX<sub>ce</sub> = -ROX<sub>dce</sub>
Use (Eq 7.2) S<sub>''E'',dce</sub> - ROX<sub>dce</sub> = S<sub>''E'',dce</sub>(mt). (mt) indicates ROX-corrected flow.
|-
| 4ceU-6ceAma
| < 3u-A >
| (Eq 20) 4ceU-6ceAma = ''E''<sub>vce</sub>(mt) + S<sub>''E'',dce</sub>(mt)
| (Eq 20.1) ET capacity, ''E''<sub>vce</sub> + S<sub>''E'',dce</sub> - ROX<sub>ce</sub> = ''E''<sub>vce</sub>(mt) +S<sub>''E'',dce</sub>(mt). (mt) indicates ROX-corrected flow.
|}
|}


:::* '''Rot and Ama control and normalization of the cell membrane permeability index, dce/ce'''
:::: '''Mortality index (Rot and Ama control)'''
::::* (Eq 21.1) dce/ce = (5ceRot-6ceAma) / (4ceU-6Ama)
::::* (Eq 21.2) dce/ce= S<sub>''E'',dce</sub>(mt) / ''E''<sub>vce</sub>(mt) + S<sub>''E'',dce</sub>(mt)
:::: '''Viability index (Rot and Ama control)'''
::::* (Eq 22.1) 1-dce/ce = vce/ce
::::* (Eq 22.1) vce/ce = ''E''<sub>vce</sub>(mt) / ''E''<sub>vce</sub>(mt) + S<sub>''E'',dce</sub>(mt)


::::* Limiting case of 100% viability (''N''<sub>vce</sub>=''N''<sub>ce</sub>): S<sub>''E'',dce</sub>(mt) = 0; vce/ce = 1
<p style="text-align:center; width:100%;">
::::* Limiting case of 0% viability (''E''<sub>vce</sub>=0; vce/ce = 0
<pic src="/images/7/7b/O2k-Oroboros-News_icon.png" width=7% height=intrinsic link="https://wiki.oroboros.at/index.php/Oroboros_News" />
:::::: If all cells are permeable (dce), then the viability index equals 0, since S<sub>''P''</sub> and ''ExR''=S<sub>''E''</sub> are practically identical in many types of mitochondria, then S<sub>''P''</sub>/S<sub>''E''</sub> = 1.
&nbsp;&nbsp;&nbsp;&nbsp;
<pic src="/images/6/6d/O2k-Publications.jpg" width=7% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Publications:_Topics" />
&nbsp;&nbsp;
<pic src="/images/4/4c/O2k-Workshops.jpg" width=7% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Events" />
&nbsp;&nbsp;
<pic src="/images/9/96/O2k-Network.png" width=7% height=intrinsic link="https://wiki.oroboros.at/index.php/O2k-Network" />
&nbsp;&nbsp;
</p>

Latest revision as of 12:22, 22 December 2022

               






             

Cookies help us deliver our services. By using our services, you agree to our use of cookies.